For research and educational purposes only. Not medical advice.
Abaloparatide Reference
Educational, not medical advice reference for Abaloparatide: Bone, Hormonal; regulatory status, evidence posture, source review, and schedule notes. Also kno…
Reference summary
Abaloparatide is a label-verified PTHrP analog with approved-label osteoporosis evidence. pepSmart surfaces label-reference content only and is not a prescribing tool.
- Categories
- Bone, Hormonal
- Aliases
- Tymlos, PTHrP analog
- Evidence posture
- human
- Regulatory status
- FDA-approved prescription medication (Tymlos). Labeled for osteoporosis treatment in postmenopausal women and in men at high risk of fracture. Cumulative lifetime exposure (teriparatide plus abaloparatide) should not exceed 2 years per label.
- Content review status
- label verified